Division of Otolaryngology, Department of Surgery, Head and Neck Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518000, PR China.
Otol Neurotol. 2024 Jun 1;45(5):475-481. doi: 10.1097/MAO.0000000000004158. Epub 2024 Feb 28.
This study aims to analyze the onset of otitis media secretory, the peak period of infection with the Omicron strain of SARS-CoV-2 virus, and the time of transmigration during a pandemic of the Omicron strain. Additionally, the study aims to investigate to study the presence of SARS-CoV-2 virus in the middle ear cavity of patients with otitis media secretory and the survival time through a new method for detecting SARS-CoV-2 virus antigen in middle ear effusion.
Retrospective comparison of the incidence of otitis media secretory during infection with SARS-CoV-2 virus Omicron strain from December 15, 2022, to January 15, 2023, versus the noninfection period from December 15, 2021, to January 15, 2022. We used a questionnaire star application to investigate the demographic and epidemiological characteristics of the 40 patients with otitis media secretory who participated in this study were investigated. A novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) was used to detect middle ear effusion in patients with otitis media secretory. The data were statistically analyzed using SPSS 29.0 software. The measurement data are expressed as x ± s , the count data are expressed as the number of cases (%), and the data were compared using the χ 2 test. p < 0.05 indicated a statistically significant difference.
During the SARS-CoV-2 virus Omicron strain pandemic, the incidence of otitis media secretory increased by 15% compared with the noninfection period. The peak infection period for the SARS-CoV-2 virus Omicron strain was December 25, 2022, and December 15, 2022, and the peak time of conversion was 7 to 9 days after the infection. Middle ear effusion SARS-CoV-2 virus antigen testing was performed in patients with otitis media secretory after conversion; 5 patients (12%) were positive, and 35 patients (88%) were negative. The disease duration in patients with negative results was more than 3 weeks.
Otitis media secretory is one of the most common ear complications after infection with the Omicron strain of SARS-CoV-2 virus, and the significantly higher incidence is associated with middle ear viral infection. Middle ear effusion SARS-CoV-2 virus antigen test detected the virus, which survived longer in the middle ear effusion than in the nasal cavity. The middle ear effusion test can detect SARS-CoV-2 virus antigen and determine whether the organism contains virus residue.
本研究旨在分析分泌性中耳炎的发病时间、感染 SARS-CoV-2 病毒奥密克戎株的高峰期以及奥密克戎株大流行期间的迁徙时间。此外,本研究旨在通过一种新的检测 SARS-CoV-2 病毒中耳腔抗原的方法,研究分泌性中耳炎患者中耳腔中 SARS-CoV-2 病毒的存在和存活时间。
对 2022 年 12 月 15 日至 2023 年 1 月 15 日感染 SARS-CoV-2 病毒奥密克戎株期间和 2021 年 12 月 15 日至 2022 年 1 月 15 日非感染期间分泌性中耳炎的发病率进行回顾性比较。我们使用问卷调查星应用程序调查了 40 名参与本研究的分泌性中耳炎患者的人口统计学和流行病学特征。使用新型冠状病毒(2019-nCoV)抗原检测试剂盒(胶体金法)检测分泌性中耳炎患者的中耳积液。使用 SPSS 29.0 软件对数据进行统计学分析。计量资料以 x ± s 表示,计数资料以例数(%)表示,采用 χ 2 检验比较数据。p<0.05 表示差异具有统计学意义。
在 SARS-CoV-2 病毒奥密克戎株流行期间,分泌性中耳炎的发病率较非感染期增加 15%。SARS-CoV-2 病毒奥密克戎株的感染高峰期为 2022 年 12 月 25 日,感染后转换时间为 7-9 天。对转换后的分泌性中耳炎患者进行中耳积液 SARS-CoV-2 病毒抗原检测,5 例(12%)阳性,35 例(88%)阴性。阴性结果患者的病程超过 3 周。
分泌性中耳炎是感染 SARS-CoV-2 病毒奥密克戎株后最常见的耳部并发症之一,其发病率显著升高与中耳病毒感染有关。中耳积液 SARS-CoV-2 病毒抗原检测可检测到病毒,该病毒在中耳积液中的存活时间长于在鼻腔中的存活时间。中耳积液检测可检测 SARS-CoV-2 病毒抗原,确定机体是否含有病毒残留。